SCHEMBL466945

SCHEMBL466945

COc1ccc(CN2CCN(Cc3cc(=O)c4ccccc4o3)CC2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.76
HTR2B P41595 7/20 0.71
HTR1A P08908 6/20 0.71
DRD2 P14416 4/20 0.71
HTR7 P34969 2/20 0.56
HTR6 P50406 2/20 0.56
ACHE P22303 3/20 0.54
BCHE P06276 2/20 0.53
KDM4E B2RXH2 1/20 0.52
NPC1 O15118 1/20 0.52
TNKS O95271 1/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52
GLA P06280 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPT P10636 1/20 0.52
THRB P10828 1/20 0.52
HPGD P15428 1/20 0.52
KCNA5 P22460 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7299921 0.86 SIGMAR1 (1.00) SIGMAR1HTR2BHTR1ADRD2ACHE
SCHEMBL7298376 0.84 SIGMAR1 (0.60) SIGMAR1HTR2BHTR1ADRD2ACHE
SCHEMBL7304042 0.84 SIGMAR1 (0.60) SIGMAR1HTR2BHTR1ADRD2KDM4E
SCHEMBL7297159 0.84 SIGMAR1 (0.81) SIGMAR1HTR2BHTR1ADRD2ACHE
SCHEMBL7299897 0.84 SIGMAR1 (0.62) SIGMAR1HTR2BHTR1ADRD2HTR7
SCHEMBL7299375 0.84 SIGMAR1 (0.69) SIGMAR1HTR2BHTR1ADRD2HTR7
SCHEMBL7303834 0.82 SIGMAR1 (0.77) SIGMAR1HTR2BHTR1ADRD2ACHE
SCHEMBL7294524 0.81 SIGMAR1 (0.76) SIGMAR1HTR2BHTR1ADRD2ACHE
SCHEMBL28316267 0.81 CYP11B1 (0.64) HTR2BKDM4ENPC1TNKSALDH1A1
SCHEMBL8946225 0.81 SIGMAR1 (0.75) SIGMAR1HTR2BHTR1ADRD2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5519023-A SCHIZOPHRENIA ADIR ET COMPAGNIE (FR) 1996-05-21 US claimed
EP-0580503-B1 Aminoalkylchromones, process for their preparation and compositions containing them ADIR (FR) 1995-06-14 EP claimed
EP-0580503-A1 Aminoalkylchromones, process for their preparation and compositions containing them ADIR ET COMPAGNIE (FR) 1994-01-26 EP claimed
EP-2600863-B1 USE OF SIGMA LIGANDS IN OPIOID-INDUCED HYPERALGESIA ESTEVE LABOR DR (ES) 2018-03-28 EP disclosed
EP-2646025-B1 USE OF SIGMA LIGANDS IN BONE CANCER PAIN ESTEVE LABOR DR (ES) 2017-03-15 EP disclosed
EP-2531191-B1 Sigma ligands for use in the prevention and/or treatment of postoperative pain ESTEVE LABOR DR (ES) 2016-03-30 EP disclosed
EP-2571501-B1 SIGMA LIGANDS FOR THE PREVENTION AND/OR TREATMENT OF EMESIS INDUCED BY CHEMOTHERAPY OR RADIOTHERAPY ESTEVE LABOR DR (ES) 2016-03-02 EP disclosed
EP-2460519-A1 Use of sigma ligands in bone cancer pain Laboratorios Del. Dr. Esteve, S.A. (ES) 2012-06-06 EP disclosed
EP-2415471-A1 Use of sigma ligands in opioid-induced hyperalgesia Laboratorios Del. Dr. Esteve, S.A. (ES) 2012-02-08 EP disclosed
EP-2388005-A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy Laboratorios Del. Dr. Esteve, S.A. (ES) 2011-11-23 EP disclosed
EP-2353598-A1 Sigma ligands for use in the prevention and/or treatment of postoperative pain Laboratorios Del. Dr. Esteve, S.A. (ES) 2011-08-10 EP disclosed
US-5519023-A SCHIZOPHRENIA ADIR ET COMPAGNIE (FR) 1996-05-21 US disclosed
EP-0580503-B1 Aminoalkylchromones, process for their preparation and compositions containing them ADIR (FR) 1995-06-14 EP disclosed
EP-0580503-A1 Aminoalkylchromones, process for their preparation and compositions containing them ADIR ET COMPAGNIE (FR) 1994-01-26 EP disclosed